|Bid||162.16 x 44200|
|Ask||162.20 x 100000|
|Day's range||161.36 - 162.78|
|52-week range||119.48 - 167.00|
|Beta (5Y monthly)||1.23|
|PE ratio (TTM)||14.65|
|Earnings date||08 Feb 2024|
|Forward dividend & yield||4.70 (2.89%)|
|Ex-dividend date||09 Feb 2024|
|1y target est||140.00|
Key Insights Siemens Healthineers' estimated fair value is €92.71 based on 2 Stage Free Cash Flow to Equity Current...
Artificial Intelligence (AI) and robotics have gotten a lot of attention as of late, and for good reason. Here's why UiPath (NYSE: PATH), Tesla (NASDAQ: TSLA), and Siemens (OTC: SIEGY) are three AI and robotics stocks worth buying now. Scott Levine (UiPath): From banks to healthcare to manufacturing, UiPath provides AI and automation solutions that make work easier for a wide variety of organizations.
Intel and Siemens on Monday announced a three-year deal to collaborate on improving factory efficiency and automation with a special focus on improving energy efficiency and sustainability. "Intel has big plans with our expansions, but we want to make sure that we do that with the utmost focus on efficiencies of natural resources and our commitments to the net zero," Intel's global operations chief Keyvan Esfarjani said in an interview with Reuters. Seeking to better compete with industry leader Taiwan Semiconductor Manufacturing (TSMC), Intel is undergoing a multi-billion-dollar shift in its manufacturing operations that includes a transition to cutting-edge chip tech known as extreme ultraviolet (EUV) lithography.